Tag: pharmaceuticals
-
Biotech, Novartis Partner on Rare Metabolic Diseases
A biotechnology start-up enterprise using genome editing for drug discovery is collaborating with drug maker Novartis on rare metabolic disorders.
-
Start-Up to Commercialize New Parkinson’s Treatment
Mavalon Therapeutics, a new company in the U.K., is being formed to bring a treatment to market that stops the progression of Parkinson’s disease.
-
Clinical Trial Network for Lupus Formed
A network of medical researchers is being assembled to conduct clinical trials to test new therapies for lupus and drugs approved for other disorders that may also treat the disease.
-
Trial Testing Retina Cell Implants for Glaucoma
A new clinical trial is testing implants to treat glaucoma made of genetically engineered retina cells that release hormones promoting optic nerve growth.
-
Therapeutic Food-Triggered Gut Microbes in Development
A biologist at Rice University in Houston is developing synthetic intestinal microbe circuits that respond to food to release therapeutic proteins.
-
Worms-On-A-Chip Drug Screening System Designed
A system using live roundworms on a microfluidics chip and high-speed image analysis can quickly and simultaneously screen nearly 100 drug compounds.
-
Trial Shows Ovarian Cancer Drug Safety, Therapy Potential
A clinical trial shows an experimental therapy addressing a common cancer-causing mutation is safe, with early indications of its efficacy against ovarian cancer.
-
Breast Cancer Drug Costs Vary Among Insured Patients
Women receiving chemotherapy for breast cancer can face widely different costs for their treatments, regardless of effectiveness, even if they have health insurance.
-
Funds Provided for Developing RNA-Based Zika Vaccine
Researchers from Infectious Disease Research Institute, or Idri, are receiving funding from National Institutes of Health to develop a new type of vaccine for the Zika virus.
-
Grant Funding Study of Gut Microbe Protection Drug
A biotechnology company developing drugs that protect the natural microbial balance in the gastrointestinal tract is receiving funds to learn how its drugs affect antibiotic resistance.